Hawaii HB820 requires health insurers to cover continuous glucose monitors for diabetes patients.

Hawaii HB820 mandates that all health insurers, including those under Medicaid managed care programs, cover continuous glucose monitors for individuals diagnosed with diabetes. This requirement applies to policies, contracts, plans, or agreements issued or renewed after December 31, 2025. Continuous glucose monitors are devices that continuously measure glucose levels, providing real-time data to help manage blood glucose levels effectively.

Hawaii HB820 requires health insurers to cover continuous glucose monitors for diabetes patients.

Hawaii HB820 mandates that all health insurers, including those under Medicaid managed care programs, cover continuous glucose monitors for individuals diagnosed with diabetes. This requirement applies to policies, contracts, plans, or agreements issued or renewed after December 31, 2025. Continuous glucose monitors are devices that continuously measure glucose levels, providing real-time data to help manage blood glucose levels effectively.